Jørgen Søberg Petersen, Senior Partner, Novo Holdings
Join us for a talk, Building Winning Biotech Companies in the Next Wave of Innovation: A Novo Holdings Investor’s Playbook, by Jørgen Søberg Petersen, Senior Partner at Novo Holdings, as he shares his perspective on what it takes to build successful biotech companies in today's rapidly evolving innovation landscape. Drawing on decades of experience spanning clinical medicine, R&D leadership, and company building, Jørgen will offer a practitioner's view of biotech investment and value creation from one of the industry's most influential life sciences investors.
About the Speaker
After 9 years in clinical and academic medicine in Denmark and in the United States, Jørgen spent 18 years in R&D Executive positions in Denmark, Switzerland, United States, France and Germany. Jørgen co-founded and built the Nasdaq-listed biotech company Zealand Pharma (ZEAL.CO), held senior leadership at Lundbeck and Novo Nordisk, and as SVP at Merck he established the Immunology franchise. He has industrial R&D experience across multiple therapeutic areas, including CNS, cardiovascular disease, diabetes, oncology and autoimmune disease, and has been involved in a number of major pharmaceutical licensing deals and alliances. Jørgen serves on the board of Acesion Pharma, Engimmune Therapeutics, Breye Therapeutics, Hemab Therapeutics, AnaCardio, Antag Therapeutics, and RheumaLogics.
Jørgen holds MD, PhD, and DMSc degrees from the University of Copenhagen and an MBA degree from the Technical University of Denmark.
Open to the Yale Community.